Levitra

today experience testosterone deficiency and researchers are now also investigating new treatments for women's arousal and desire.

Acrux is at the forefront of this exciting and growing area, with three women's health products and one men's health product in development using the company's transdermal delivery system.

"Our vision is that Acrux's once-a-day skin sprays will become a familiar and preferred means of treatment for women throughout their lives," said Wilkins.

"Our contraceptive, our treatment for decreased libido and our treatment for menopausal symptoms are all in clinical development, with the first product nearing completion of Phase 3 in the USA.

We are also developing a novel patient-friendly lotion for men faced with testosterone deficiency." Acrux's transdermal drug delivery system consists of three proprietary components: - MDTS(R) applicator-a small, hand-held, easy-to-use applicator that is designed to provide an easy and convenient means to deliver a preset dose of a therapeutic drug onto the skin - ACROSS(R) penetration enhancers-commonly used safe, non-irritating materials, with properties that enable transport of the drug through the skin.

- Patchless Patch(R)-the drug delivery method itself, whereby a fast-drying formulation forms an invisible reservoir of the drug and enhancer in the outer l...

Read more...